Robotic Partial Nephrectomy Outcomes Worse When PSMs Are Present
Positive surgical margins in patients undergoing robotic partial nephrectomy for renal tumors are associated with adverse oncologic outcomes, a study revealed.
Positive surgical margins in patients undergoing robotic partial nephrectomy for renal tumors are associated with adverse oncologic outcomes, a study revealed.
An interim analysis suggests that axitinib given to patients with complex clear cell renal cell carcinoma tumors significantly reduces tumor size and complexity.
Findings may inform surveillance strategies and improve treatment outcomes.
Immune checkpoint inhibitors may be more beneficial than tyrosine kinase inhibitors for patients undergoing cytoreductive nephrectomy for metastatic renal cell carcinoma.
Incidence of major complications after hand-assisted laparoscopic living donor nephrectomy low at 2.5%
In a study of patients with RCC and venous thrombus who underwent radical nephrectomy and venous thrombectomy, the median overall survival was 56 months.
A minimally invasive approach does not increase risk for atypical sites of kidney cancer recurrence, a recent study suggests.
In the era of immune checkpoint inhibitors, cytoreductive nephrectomy retains an important role in mRCC in carefully selected patients, according to investigators.
Screening for sarcopenia may assist in identifying patients at high risk for increased perioperative morbidity, according to investigators.
Even in the highest quartile of neighborhood socioeconomic status, Black patients were significantly less likely to receive partial nephrectomy for localized renal masses compared with White patients.